Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
In the last 90 days, Passage BIO, Inc. insiders filed 1 open-market purchase and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Passage BIO, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +1 vs. Q2 2024
- Shares held
- 38.7M
- −792.8K (−2.0%) vs. Q2 2024
- Total value
- $27.1M
- −$4.28M (−13.7%) vs. Q2 2024
- New holders
- 10
- 8 more added
- Sold out
- 9
- 7 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $33.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.1M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 9,822,876 | $6.88M | 0.13% | −301,700−3.0% | Reduced |
| Lynx1 Capital Management LP | 8,426,955 | $5.90M | 2.09% | +3,369,326+66.6% | Added |
| Vestal Point Capital, LP | 6,100,000 | $4.27M | 0.34% | +48,000+0.8% | Added |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1.75M | 1.80% | 00.0% | Unchanged |
| Erste Asset Management GmbH | 2,455,800 | $1.72M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,071,538 | $1.45M | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,500,000 | $1.05M | 0.08% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,392,846 | $975.0K | 0.00% | +267,272+23.7% | Added |
| Acadian Asset Management LLC | 961,271 | $671.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 721,735 | $505.2K | 0.00% | +721,735 | New |
| Bridgeway Capital Management, LLC | 556,142 | $389.3K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 509,516 | $356.7K | 0.00% | +78,406+18.2% | Added |
| Citadel Advisors LLC | 402,525 | $281.8K | 0.00% | +244,264+154.3% | Added |
| Fiduciary Trust Co | 215,000 | $150.5K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 163,859 | $114.7K | 0.00% | −587,067−78.2% | Reduced |
| RBF Capital, LLC | 142,807 | $100.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 123,873 | $86.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 98,041 | $68.6K | 0.00% | −5,813−5.6% | Reduced |
| Shay Capital LLC | 92,256 | $64.6K | 0.02% | +92,256 | New |
| DLK Investment Management, LLC | 64,000 | $44.8K | 0.02% | 00.0% | Unchanged |
| Landscape Capital Management, L.L.C. | 53,915 | $37.7K | 0.00% | +53,915 | New |
| Northern Trust Corp | 40,281 | $28.2K | 0.00% | −24,231−37.6% | Reduced |
| Engineers Gate Manager LP | 34,770 | $24.3K | 0.00% | +34,770 | New |
| XTX Topco Ltd | 29,590 | $20.7K | 0.00% | +12,551+73.7% | Added |
| Squarepoint Ops LLC | 27,927 | $19.5K | 0.00% | +27,927 | New |
| Goldman Sachs Group Inc | 27,072 | $18.9K | 0.00% | −161−0.6% | Reduced |
| Cresset Asset Management, LLC | 23,725 | $16.6K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 22,852 | $16.0K | 0.00% | +1,798+8.5% | Added |
| Two Sigma Securities, LLC | 21,635 | $15.1K | 0.00% | +21,635 | New |
| HighTower Advisors, LLC | 16,380 | $11.0K | 0.00% | −5,132−23.9% | Reduced |
| Morgan Stanley | 13,442 | $9.41K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 13,153 | $9.21K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 12,271 | $8.59K | 0.00% | +12,271 | New |
| Tower Research Capital LLC (TRC) | 5,030 | $3.52K | 0.00% | −8,173−61.9% | Reduced |
| Nordwand Advisors, LLC | 2,500 | $1.75K | 0.00% | +2,500 | New |
| Advisor Group Holdings, Inc. | 1,770 | $1.24K | 0.00% | +1,770 | New |
| Federated Hermes, Inc. | 783 | $548 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 425 | $298 | 0.00% | +58+15.8% | Added |
| JPMorgan Chase & Co | 273 | $191 | 0.00% | 00.0% | Unchanged |
| LRI Investments, LLC | 225 | $133 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 64 | $45 | 0.00% | +64 | New |
| Harbour Investments, Inc. | 60 | $42 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 47 | $33 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 0 | $0 | 0.00% | −4,026,417−100.0% | Sold out |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −471,812−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −264,266−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −85,500−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −693−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,146−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −783−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |